BOMMARITO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.114
EU - Europa 629
AS - Asia 162
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 1.910
Nazione #
US - Stati Uniti d'America 1.112
FI - Finlandia 189
IT - Italia 125
UA - Ucraina 119
CN - Cina 116
IE - Irlanda 45
DE - Germania 43
SE - Svezia 29
GB - Regno Unito 24
SG - Singapore 20
RU - Federazione Russa 18
BE - Belgio 12
IN - India 12
FR - Francia 10
IR - Iran 7
RO - Romania 4
CH - Svizzera 3
EU - Europa 3
NL - Olanda 3
CA - Canada 2
CZ - Repubblica Ceca 2
KR - Corea 2
PL - Polonia 2
AU - Australia 1
CI - Costa d'Avorio 1
HK - Hong Kong 1
ID - Indonesia 1
JP - Giappone 1
NO - Norvegia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 1.910
Città #
Ann Arbor 165
Ashburn 96
Fairfield 90
Chandler 72
Jacksonville 71
Woodbridge 71
Houston 62
Wilmington 49
Dublin 45
Palermo 38
Cambridge 34
Seattle 31
Medford 30
New York 30
Des Moines 23
Dearborn 22
Princeton 20
Boardman 19
Nanjing 17
Tulsa 14
Hebei 13
Brussels 12
Changsha 12
Shenyang 10
Guangzhou 9
Jinan 9
Kumar 8
Singapore 8
Beijing 7
Nanchang 7
Saint Petersburg 7
Venice 7
Ningbo 6
Altamura 5
Falls Church 5
Haikou 5
Lawrence 5
Ludwigshafen am Rhein 5
Munich 5
San Diego 5
Tianjin 5
Verona 5
Washington 5
Durham 4
Jiaxing 4
San Cataldo 4
Tehran 4
Bologna 3
Hangzhou 3
Orange 3
Auburn Hills 2
Berlin 2
Bremen 2
Brno 2
Catania 2
Chicago 2
Düsseldorf 2
Los Angeles 2
Mehlingen 2
Negar 2
Perugia 2
Phoenix 2
Piscataway 2
Rome 2
San Mateo 2
Seongnam 2
Zhengzhou 2
Abidjan 1
Amsterdam 1
Andover 1
Central 1
Changchun 1
Edmonton 1
Foggia 1
Frankfurt Am Main 1
Fuzhou 1
Greifswald 1
Groningen 1
Harbin 1
Hefei 1
Helsinki 1
Hounslow 1
Izmir 1
Jakarta 1
Leawood 1
London 1
Milan 1
Moscow 1
New Haven 1
Norwalk 1
Prescot 1
Pune 1
Redwood City 1
Rotterdam 1
San Paolo di Civitate 1
Shahid Madani 1
Southwark 1
Taiyuan 1
Taizhou 1
Tokyo 1
Totale 1.256
Nome #
In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line 176
In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines 172
BRAFV600E mutation, TIMP-1 up-regulation and NF-{kappa}B activation: closing the loop on the papillary thyroid cancer trilogy. 172
Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. 155
Fine-Needle Aspiration (FNAB) Molecular Analysis for the Diagnosis of Papillary Thyroid Carcinoma through BRAFv600E mutation and RET/PTC rearrangement 150
BrafV600E mutation and hyperexpression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in papillary thyroid carcinoma 98
A type I Interferon (IFN-α)-induced distal enhancer differentially regulates the P1 and P2 c-Myc promoters. 89
Analisi dei meccanismi di controllo dell’apoptosi in una linea cellulare β-pancreatica resistente all’effetto delle citochine. 87
ISOLAMENTO E CARATTERIZZAZIONE DI CELLULE STAMINALI NELLE LINEE CELLULARI DI CARCINOMA TIROIDEO 85
Identification and enrichment of thyroid stem cells in anaplastic cell lines 82
No association between BRAFV660E and metalloproteinase activity in anaplastic thyroid cell lines 82
BRAFV600E mutation and timp-1 hyper-expression in classical variants of papillary thyroid carcinoma (PTC). 79
Limbal stem cells as a potential source of pancreatic beta cells 76
BRAFV660E mutation and Timp-1 hyper-expression in classical variants of papyllary thyroid carcinoma. 74
Functional and molecular charecterizzation of cancer stam cells in anaplastic thyroid carcinoma 72
SYNTHESIS AND CHARACTERIZATION OF POSITIVELY CHARGED FUNCTIONALIZED HALLOYSITE/CURCUMIN SYSTEMS AND EVALUATION OF THEIR ANTICANCER ACTIVITY 72
Molecular characterization of cancer stem cells in anaplastic thyroid carcinoma 71
Antitumor effect of aminobisphosphonates on anaplastic thyroid carcinoma cell lines. 70
Differential protein expression in cytokine-sensitive and -resistant pancreatic beta cell lines 70
A type I interferon (IFN)-induced distal enhancer differentially regulates the P1 and P2 c-Myc promoters 61
Totale 1.993
Categoria #
all - tutte 5.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020426 62 34 28 21 50 50 40 25 35 15 49 17
2020/2021243 7 26 18 21 20 5 28 11 49 8 27 23
2021/2022267 2 55 2 3 29 7 11 17 28 33 22 58
2022/2023239 28 27 5 27 26 43 21 9 35 4 12 2
2023/2024214 5 24 13 27 21 63 9 11 1 4 9 27
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.993